Can we optimize the selection of patients with lung cancer suitable for EGFR+MET double inhibition?

Alessandro Leonetti, Marcello Tiseo, Christian Rolfo, Nele Van Der Steen, Godefridus J. Peters, Elisa Giovannetti

Research output: Contribution to journal › Letter › Academic › peer-review

1 Citation (Scopus)

Original language	English
Journal	JCO Precision Oncology
Volume	3
DOIs	https://doi.org/10.1200/PO.19.00180
Publication status	Published - 1 Jan 2019

Access to Document

https://doi.org/10.1200/PO.19.00180

Other files and links

Link to publication in Scopus

Cite this

@article{b140036b2a684665b5211440442876d8,

title = "Can we optimize the selection of patients with lung cancer suitable for EGFR+MET double inhibition?",

author = "Alessandro Leonetti and Marcello Tiseo and Christian Rolfo and {Van Der Steen}, Nele and Peters, {Godefridus J.} and Elisa Giovannetti",

year = "2019",

month = jan,

day = "1",

doi = "https://doi.org/10.1200/PO.19.00180",

language = "English",

volume = "3",

journal = "JCO Precision Oncology",

issn = "2473-4284",

publisher = "American Society of Clinical Oncology",

}

TY - JOUR

T1 - Can we optimize the selection of patients with lung cancer suitable for EGFR+MET double inhibition?

AU - Leonetti, Alessandro

AU - Tiseo, Marcello

AU - Rolfo, Christian

AU - Van Der Steen, Nele

AU - Peters, Godefridus J.

AU - Giovannetti, Elisa

PY - 2019/1/1

Y1 - 2019/1/1

UR - http://www.scopus.com/inward/record.url?scp=85086241036&partnerID=8YFLogxK

U2 - https://doi.org/10.1200/PO.19.00180

DO - https://doi.org/10.1200/PO.19.00180

M3 - Letter

SN - 2473-4284

VL - 3

JO - JCO Precision Oncology

JF - JCO Precision Oncology

ER -